US2006111562A1PendingUtilityA1
Human SDF-5 protein and compositions
Est. expiryFeb 6, 2017(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/00A61P 35/00A61P 3/10A61P 37/02A61P 33/00A61P 31/12A61P 37/08A61P 37/04A61P 5/06A61P 37/06A61P 7/02A61P 9/10A61P 31/00A61P 29/00A61P 31/04A61P 27/02A61P 25/24A61P 31/10A61P 25/02A61P 25/14A61P 25/28A61P 25/16A61P 3/02A61P 1/00A61P 11/00A61K 38/00A61P 11/06A61P 1/18A61P 21/04C07K 14/52A61P 19/04A61P 19/08A61P 19/02A61P 15/16A61P 19/00A61P 13/12A61P 1/04A61P 17/02C12N 15/11
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Purified human SDF-5 proteins and processes for producing them are disclosed. DNA molecules encoding the human SDF-5 proteins are also disclosed. The proteins may be used in regulating the binding of Wnt genes to their receptor. In preferred embodiments, the proteins may be used for inducing formation, growth, differentiation, proliferation and/or maintenance of chondrocytes and/or cartilage tissue, and for other tissue repair, such as pancreatic tissue repair.
Claims
exact text as granted — not AI-modified1 . An isolated or recombinant polynucleotide comprising the nucleotide sequence from nucleotide #328 to #1140 of SEQ ID NO: 1.
2 . The polynucleotide of claim 1 , wherein said polynucleotide comprises a nucleotide sequence selected from the group consisting of:
the nucleic sequence from nucleotide #256 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #307 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #310 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #313 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #316 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #319 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #322 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #325 to #1140 of SEQ ID NO: 1, the nucleic sequence from nucleotide #256 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #307 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #310 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #313 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #316 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #319 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #322 to #1143 of SEQ ID NO: 1, the nucleic sequence from nucleotide #325 to #1143 of SEQ ID NO: 1, and the nucleic sequence from nucleotide #328 to #1143 of SEQ ID NO: 1.
3 . An isolated or recombinant polynucleotide comprising a nucleotide sequence encoding the amino acid sequence from amino acid #25 to #295 of SEQ ID NO: 2.
4 . The polynucleotide of claim 3 , wherein said polynucleotide comprises a nucleotide sequence encoding an amino acid sequence selected from the group consisting of:
the amino acid sequence from amino acid #1 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #18 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #19 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #20 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #21 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #22 to #295 of SEQ ID NO:2, the amino acid sequence from amino acid #23 to #295 of SEQ ID NO:2, and the amino acid sequence from amino acid #24 to #295 of SEQ ID NO:2.
5 . A vector comprising the polynucleotide of claim 3 .
6 . A vector comprising the polynucleotide of claim 3 operatively associated with an expression control sequence.
7 . A cell comprising the vector of claim 6 .
8 . A cell comprising the polynucleotide of claim 3 .
9 . An isolated or recombinant polynucleotide which is capable of hybridizing under stringent hybridization conditions to the polynucleotide of claim 1 and encodes a protein having Frazzled activity.Join the waitlist — get patent alerts
Track US2006111562A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.